Ypsomed Holding AG reported earnings results for the half year ended September 30, 2023. For the half year, the company reported net income was CHF 36.58 million compared to CHF 15.44 million a year ago. Basic earnings per share from continuing operations was CHF 2.68 compared to CHF 1.17 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
332 CHF | 0.00% | -0.45% | +9.57% |
Apr. 16 | Ypsomed Partners with ten23 health for Wearable Injector Product Commercialization | MT |
Apr. 12 | Dental Equipment Company Straumann Names New Chair | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.57% | 5B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- YPSN Stock
- News Ypsomed Holding AG
- Ypsomed Holding AG Reports Earnings Results for the Half Year Ended September 30, 2023